🏛️ Verified NIH Record • Updated 2025-08-18
Melatonin and Osteogenic Loading on Osteopenia (NCT04233112)
Assessing the Efficacy of Melatonin and Osteogenic Loading on Bone Health in an Osteopenic Population: MelaOstrong Study
🔵 Active, Not Recruiting Early Phase1 💊 Investigational Drug / Biologic Sponsor: Duquesne University
🩺 Plain-English Summary (8th-Grade Level)
This study will be assessing the efficacy of melatonin and/or osteogenic loading on modulating bone health in an osteopenic population.
Who can join: Review the eligibility criteria below.
Location: OsteoStrong® in Scott Towne Center — Pittsburgh, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- OsteoStrong® in Scott Towne Center — Pittsburgh, Pennsylvania
- Duquesne University — Pittsburgh, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteopenia
- Calcium-Rich Food Versus Calcium Carbonate for Bone Health — New York, New York
- Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia — Boston, Massachusetts
Explore by condition: All Osteopenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.